Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)

The summary for the Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03): -Purpose. Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (S and T) Sub-Commission, the Gandhi-Reagan S and T Initiative, the U.S.-India Fund, and the current S and T Cooperation Agreement. Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research. The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. -Mechanism of Support. This funding opportunity announcement (FOA) solicits Small Research Grant (R03) applications, which will provide U.S. dollar support of vaccine-related research in India and the United States and augment current VAP activities. Investigators from U.S. and Indian institutions are eligible to apply. -Applications are solicited from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis.